Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp.

Journal of the Medical Association of Thailand

Volumn 83, Issue 1, 2000, Pages 57-60

  Srimuang, Somboon ^a   Chaiprasert, Angkana ^c   Tanphaichitra, Deja ^a   Prariyachatigul, Chularut ^b   Rungsipanuratn, Watcharin ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Amphotericin B; Cryptococcus neoformans; Drug combination; Prototheca spp.

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCYTOSINE; RIFAMPICIN;

ARTICLE; CHLORELLA; CRYPTOCOCCUS NEOFORMANS; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CRYPTOCOCCUS NEOFORMANS; DRUG THERAPY, COMBINATION; FLUCYTOSINE; HUMANS; MICROBIAL SENSITIVITY TESTS; PROTOTHECA; SENSITIVITY AND SPECIFICITY;

EID: 0034099761     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kwan-Chung KJ. Medical Mycology. Lea & Febiger, Pennsylvania 1992: 89-90.
2. Rippon JW. Medical Mycology. WB Saundus Co., Philadelphia. 1982: 721-38.
3. Tanphaichitra D, Srimuang S, Sahaphong S. Serological diagnosis of cryptococcosis and serotyping of Cryptococcus neoformans. In : Diagnosis and therapy of systemic fungal infections. Edited by K. Holmberg and R. Meyer. Raven Press Ltd. 1990, p 115-121 and in : Clin Pharmacol Res 1988; 8: 433-9.
4. Tanphaichitra D, Srimuang S, Sahaphong S. Serological diagnosis of cryptococcosis and serotyping of Cryptococcus neoformans. In : Diagnosis and therapy of systemic fungal infections. Edited by K. Holmberg and R. Meyer. Raven Press Ltd. 1990, p 115-121 and in : Clin Pharmacol Res 1988; 8: 433-9.
5. Arroya J, Medoff G, Kobayashi GS. Therapy of murine aspergillosis with amphotericin in combination with rifampin or 5-flucytosine. Antimicrob Agents Chermother 1977;11:21-5.
6. Hugues CE, Harris C, Moody JA, Peterson LR, Gerding D. In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp. Antimicrobial Agents Chemother 1984;25:560-2.
7. Ribner B, Keusch GT, Hanna BA, Perloff M. Combination amphotericin B - rifampin therapy for pulmonary aspergillus in leukemia patient. Chest 1976;70:681-3.
8. Srimuang S, Tanphaichitra D. In vitro activities of Amphotericin B in combination with rifampin VS flucytosine against C.neoformans, Prototheca. (Letter to editor) J Mycol Med 1994;4:55.
9. Tucker RM, Denning DW, Hanson DW, et al. Interaction of azole with rifampin, phenytoin and carbamazepine : In vitro and clinical observations. Clin Infect Dis 1992;14:165-74.
10. Coker RJ, Tomloson H, Parkin J, Harris JRW, Pinching AJ. Interaction between fluconazole and rifampin (correspondance). Brit Med J 1990;301: 818.
11. Medoff G, Kobayashi GS, Kwan CN, et al. Potentiation of rifampin and 5-FC as antifungal antibiotics by amphotericin B. Proc Natl Acad Sci USA 1972;69:196-9.
12. Beggs WH, Sarosi LA, Andrew FA. Synergistic action of amphotericin B and rifampin on Candida albicans. Am Rev Respir Dis 1974;110: 671-3.